tradingkey.logo

LENSAR Inc

LNSR

12.975USD

+0.365+2.89%
Market hours ETQuotes delayed by 15 min
152.98MMarket Cap
LossP/E TTM

LENSAR Inc

12.975

+0.365+2.89%
More Details of LENSAR Inc Company
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
Company Info
Ticker SymbolLNSR
Company nameLENSAR Inc
IPO dateSep 21, 2020
CEOMr. Nicholas T. (Nick) Curtis
Number of employees140
Security typeOrdinary Share
Fiscal year-endSep 21
Address2800 Discovery Drive
CityORLANDO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code32826
Phone18885367271
Websitehttps://www.lensar.com/
Ticker SymbolLNSR
IPO dateSep 21, 2020
CEOMr. Nicholas T. (Nick) Curtis
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.36%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+3.08%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+8.62%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+9.12%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.36%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+3.08%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+8.62%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+9.12%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
United States
6.70M
54.57%
Asia (excluding South Korea)
3.08M
25.05%
Europe
2.25M
18.30%
South Korea
188.00K
1.53%
Other
67.00K
0.55%
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Jul 29
Updated: Tue, Jul 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
North Run Capital, LP
9.33%
Curtis (Nicholas T)
6.72%
Link (William J)
4.67%
Brandes Investment Partners, L.P.
4.62%
Dimensional Fund Advisors, L.P.
4.05%
Other
70.61%
Shareholders
Shareholders
Proportion
North Run Capital, LP
9.33%
Curtis (Nicholas T)
6.72%
Link (William J)
4.67%
Brandes Investment Partners, L.P.
4.62%
Dimensional Fund Advisors, L.P.
4.05%
Other
70.61%
Shareholder Types
Shareholders
Proportion
Individual Investor
19.94%
Hedge Fund
17.40%
Investment Advisor
15.80%
Investment Advisor/Hedge Fund
7.71%
Bank and Trust
1.44%
Research Firm
1.31%
Pension Fund
1.09%
Other
35.31%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
120
7.63M
64.70%
+228.90K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
2023Q3
96
7.03M
62.74%
-797.20K
2023Q2
103
7.07M
63.18%
-1.15M
2023Q1
134
7.30M
65.81%
-830.17K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
North Run Capital, LP
1.10M
9.33%
--
--
Mar 23, 2025
Curtis (Nicholas T)
792.29K
6.72%
--
--
May 15, 2025
Link (William J)
550.64K
4.67%
+7.37K
+1.36%
May 23, 2025
Brandes Investment Partners, L.P.
544.69K
4.62%
+55.37K
+11.32%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
477.70K
4.05%
-136.68K
-22.25%
Mar 31, 2025
The Vanguard Group, Inc.
442.50K
3.75%
+9.02K
+2.08%
Mar 31, 2025
Renaissance Technologies LLC
313.64K
2.66%
-35.25K
-10.10%
Mar 31, 2025
Connaughton (Alan B.)
279.22K
2.37%
--
--
May 15, 2025
Tudor Investment Corporation
277.00K
2.35%
+277.00K
--
Mar 31, 2025
Lindstrom (Richard L)
246.41K
2.09%
+7.37K
+3.08%
May 23, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Franklin US Small Cap Multifactor Index ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI